TARGETS AND AGENTS FOR THE TREATMENT OF IMPAIRED BONE FRACTURE HEALING

The application teaches a composition comprising one or more pharmaceutical active ingredients selected from the group consisting of interleukin-8 (IL-8 or CXCL8), a functional fragment of IL-8, a functional variant of IL-8, and an agonist of IL-8 receptor, for therapeutic and/orprophylactic interve...

Full description

Saved in:
Bibliographic Details
Main Authors ALBARANI VALENTINA, GANGJI VALERIE, BASTIANELLI ENRICO, PESESSE XAVIER, DE SENY DOMINIQUE, MATHIEU MYRIELLE, MALAISE MICHEL, INGELS AUDE, RIGUTTO SABRINA, HAUZEUR JEAN-PHILIPPE, SPRUYT DELPHINE
Format Patent
LanguageEnglish
Published 31.07.2014
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The application teaches a composition comprising one or more pharmaceutical active ingredients selected from the group consisting of interleukin-8 (IL-8 or CXCL8), a functional fragment of IL-8, a functional variant of IL-8, and an agonist of IL-8 receptor, for therapeutic and/orprophylactic interventions in impaired bone fracture healing, such as but not limited to non-union fractures, mal-union fractures, or delayed union fractures.
Bibliography:Application Number: US201214124165